Cat. No. | Product name | CAS No. |
DCC5219 |
Trans-ocma
Natural specific inhibitor of γ-secretase, decreasing amyloid-beta levels without influencing cleavage of Notch, showing strong growth inhibitory effects on cancer cell lines and significant anti-complement activity, also acting as a PTP1B inhibitor |
|
DCC5220 |
trans-resveratrol-3-o-glucuronide
Metabolite of Resveratrol |
387372-17-0 |
DCC5221 |
trans-resveratrol-4'-o-glucuronide
Metabolite of Resveratrol |
387372-20-5 |
DCC5222 |
Trantinterol
Novel Highly Selective β2-Adrenoceptor Agonist as an Oral Antiasthmatic Agent |
611234-02-7 |
DCC5223 |
trapoxin B
Inhibitor of histone deacetylases |
133155-90-5 |
DCC5224 |
Trc210258
Novel TGR5 agonist, reducing glycemic and dyslipidemic cardiovascular risk in animal models of diabesity |
1431553-15-9 |
DCC5225 |
Trehalose-6-phosphate
Central sugar signal in plants, regulating sucrose use and allocation, underpinning crop growth and development |
4484-88-2 |
DCC5226 |
Trenbolone Enanthate
Potent and long-acting derivative of the hormone Trenbolone |
1629618-98-9 |
DCC5227 |
Triazophos
EC 3.1.1.7 (Acetylcholinesterase) inhibitor, acting as an insecticide, an acaricide, an agrochemical, and a nematicide |
24017-47-8 |
DCC5228 |
Triciribine Phosphate
AKT Inhibitor, Enhancing Gemcitabine Activity in Pancreatic Cancer Cells |
61966-08-3 |
DCC5229 |
Tridecyl 2-aminoacetate Hydrochloride
Potent NAE-hydrolyzing acid amidase (NAAA) inhibitor |
94856-88-9 |
DCC5230 |
Trifluoperazine N-glucuronide
Metabolite of Trifluoperazine; Antidepressant and antipsychotic |
165602-90-4 |
DCC5231 |
Trifluoroacetyl Lysine
Novel Bromodomain Binding Mimic of Lysine Acetylation |
10009-20-8 |
DCC5232 |
Trigonellinamide
Metabolite of nicotinamide; Specific and potent inhibitor of NNMT, increasing histone methylation at H3K4 and methylated H3K4 occupancy at gene promoters |
3106-60-3 |
DCC5233 |
Trimipramine
Antipsychotic and sedative agent as a potent antagonist of H1, 5-HT2A, and alpha1-adrenergic receptors |
739-71-9 |
DCC5234 |
Tripartin
Specific inhibitor of the histone H3 lysine 9 demethylase KDM4 in HeLa cells. |
1428962-73-5 |
DCC5235 |
Triplin
Copper ion chelator, causing the triple response phenotype by affecting copper ion transport in ethylene signaling from ATX1 to RAN1 |
1421584-86-2 |
DCC5236 |
Tritiozine
Novel anti-secretory and antiulcer agent for treatment of peptic ulcer disease and hypersecretory disorders |
35619-65-9 |
DCC5237 |
Trk Inhibitor 7d
First Highly Selective and Broadly Effective Macrocycle-Based Type II TRK Inhibitor that Overcome Clinically Acquired Resistance |
|
DCC5238 |
Trk-130
Novel opioid ligand for treatment of overactive bladder, acting as a μ-opioid receptor partial agonist |
160359-68-2 |
DCC5239 |
Trka-in-1
Novel potent and selective inhibitor of Tropomyosin-related kinase A (TrkA) |
|
DCC5240 |
trmd-in-51
First-in-class highly potent and selective inhibitor of TrmD (bacterial t-RNA-(N1G37) methyltransferase) |
1456890-42-8 |